However, estrogen may be important in the pathogenesis of BRCA1-associated BC [27] and tamoxifen and raloxifene may act as preventive agents in BRCA1 carriers by binding to estrogen receptor beta [28]. This evidence concerns the gene BRCA1 and breast cancer.